<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="discussion" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31616475</article-id>
<article-id pub-id-type="pmc">6764389</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2019.00892</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Opinion</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Chromosome Instability in the Neurodegenerating Brain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yurov</surname>
<given-names>Yuri B.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vorsanova</surname>
<given-names>Svetlana G.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/687148" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iourov</surname>
<given-names>Ivan Y.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/46339" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup><institution>Yurov’s Laboratory of Molecular Genetics and Cytogenomics of the Brain, Mental Health Research Center</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<aff id="aff2">
<sup>2</sup><institution>Laboratory of Molecular Cytogenetics of Neuropsychiatric Diseases, Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Anja Weise, University Hospital Jena, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Maik Werner Kschischo, Koblenz University of Applied Sciences, Germany; Natalay Kouprina, National Cancer Institute at Frederick, United States</p>
</fn>
<corresp id="fn001">*Correspondence: Ivan Y. Iourov, <email xlink:href="mailto:ivan.iourov@gmail.com" xlink:type="simple">ivan.iourov@gmail.com</email>
</corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Genomic Medicine, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>892</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>6</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Yurov, Vorsanova and Iourov</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Yurov, Vorsanova and Iourov</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<kwd-group>
<kwd>brain</kwd>
<kwd>chromosome insatiability</kwd>
<kwd>neurodegeneration</kwd>
<kwd>pathways</kwd>
<kwd>aneuploidy</kwd>
<kwd>genome stability</kwd>
<kwd>somatic mosaicism</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Russian Foundation for Basic Research<named-content content-type="fundref-id">10.13039/501100002261</named-content></funding-source>
<award-id rid="cn001">18-515-34005</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="36"></ref-count>
<page-count count="4"></page-count>
<word-count count="2262"></word-count>
</counts>
</article-meta>
</front>
<body>
<p>Chromosome instability (CIN) is a hallmark of cancer (<xref ref-type="bibr" rid="B11">Heng, 2015</xref>; <xref ref-type="bibr" rid="B24">Rangel et al., 2017</xref>; <xref ref-type="bibr" rid="B22">Machiela, 2019</xref>; <xref ref-type="bibr" rid="B27">Simonetti et al., 2019</xref>). Additionally, a number of neurodegenerative diseases (NDD) demonstrate CIN, which mediates neuronal cell loss and appears to be a key element of the pathogenic cascade (<xref ref-type="bibr" rid="B12">Iourov et al., 2009a</xref>; <xref ref-type="bibr" rid="B13">Iourov et al., 2009b</xref>; <xref ref-type="bibr" rid="B2">Arendt et al., 2010</xref>; <xref ref-type="bibr" rid="B17">Jeppesen et al., 2011</xref>; <xref ref-type="bibr" rid="B8">Driver, 2012</xref>; <xref ref-type="bibr" rid="B4">Bajic et al., 2015</xref>; <xref ref-type="bibr" rid="B20">Leija-Salazar et al., 2018</xref>; <xref ref-type="bibr" rid="B23">Nudelman et al., 2019</xref>). Moreover, CIN is repeatedly associated with aging and aging-related deterioration of the brain (<xref ref-type="bibr" rid="B33">Yurov et al., 2010</xref>; <xref ref-type="bibr" rid="B18">Kennedy et al., 2012</xref>; <xref ref-type="bibr" rid="B1">Andriani et al., 2017</xref>; <xref ref-type="bibr" rid="B29">Vijg et al., 2017</xref>; <xref ref-type="bibr" rid="B36">Zhang and Vijg, 2018</xref>). Despite numerous studies dedicated to CIN in NDD, there is still no clear understanding of differences between “cancerous” and “neurodegenerative” CINs. Here, we propose a theoretical model, which seems to highlight the differences between these CIN types.</p>
<p>Oncogenic parallels have long been observed in NDD. More specifically, CIN manifesting as aneuploidy (gains or losses of whole chromosomes) has been systematically identified in the brain of individuals with NDD. The Alzheimer’s disease brain has been found to demonstrate high rates of spontaneous aneuploidy (<xref ref-type="bibr" rid="B13">Iourov et al., 2009b</xref>; <xref ref-type="bibr" rid="B14">Iourov et al., 2011</xref>; <xref ref-type="bibr" rid="B31">Yurov et al., 2014</xref>; <xref ref-type="bibr" rid="B4">Bajic et al., 2015</xref>; <xref ref-type="bibr" rid="B3">Arendt et al., 2017</xref>; <xref ref-type="bibr" rid="B32">Yurov et al., 2018</xref>). Furthermore, Alzheimer’s disease genes are involved in molecular pathways, alterations to which result in chromosome mis-segregation and aneuploidy (<xref ref-type="bibr" rid="B10">Granic et al., 2010</xref>). Similarly, CIN syndromes and/or mutations in genes involved in cell cycle/mitotic checkpoint pathways exhibit brain-specific CIN associated with neurodegeneration. Thus, CIN has been demonstrated to underlie neurodegenerative processes (<xref ref-type="bibr" rid="B12">Iourov et al., 2009a</xref>; <xref ref-type="bibr" rid="B7">Caneus et al., 2018</xref>; <xref ref-type="bibr" rid="B20">Leija-Salazar et al., 2018</xref>). Additionally, submicroscopic CIN producing structural rearrangements of the <italic>APP</italic> gene (21q21.3) has been shown to be involved in neurodegenerative pathways to Alzheimer’s disease (<xref ref-type="bibr" rid="B6">Bushman et al., 2015</xref>; <xref ref-type="bibr" rid="B19">Lee et al., 2018</xref>). It is important to note that numerical CIN (aneuploidy) is shown to be implicated in the neurodegeneration pathway inasmuch as the neurons affected by CIN/aneuploidy are susceptible to selective cell death (<xref ref-type="bibr" rid="B2">Arendt et al., 2010</xref>; <xref ref-type="bibr" rid="B9">Fricker et al., 2018</xref>; <xref ref-type="bibr" rid="B16">Iourov et al., 2019</xref>). Finally, DNA repair deficiency (<xref ref-type="bibr" rid="B17">Jeppesen et al., 2011</xref>) and DNA replication stress (<xref ref-type="bibr" rid="B34">Yurov et al., 2011</xref>) have been identified as possible mechanisms for neurodegeneration.</p>
<p>Another body of evidence for the contribution of CIN to neurodegeneration is provided by brain aging studies. Actually, CIN and related phenomena (aneuploidization, somatic mutagenesis, etc.) are considered to be elements of a global pathogenic cascade resulting in aging phenotypes (<xref ref-type="bibr" rid="B18">Kennedy et al., 2012</xref>; <xref ref-type="bibr" rid="B28">Vijg, 2014</xref>; <xref ref-type="bibr" rid="B1">Andriani et al., 2017</xref>). Progressive accumulation of somatic chromosomal mutations (aneuploidy) causing numerical CIN is suggested to be implicated in cellular senescence and tissue aging (<xref ref-type="bibr" rid="B33">Yurov et al., 2010</xref>; <xref ref-type="bibr" rid="B36">Zhang and Vijg, 2018</xref>; <xref ref-type="bibr" rid="B16">Iourov et al., 2019</xref>). For instance, rates of X chromosome aneuploidy increase with age in the Alzheimer’s disease brain (<xref ref-type="bibr" rid="B31">Yurov et al., 2014</xref>). It is to note that X chromosome aneuploidy (loss/monosomy) is a cytogenetic biomarker of human aging (<xref ref-type="bibr" rid="B28">Vijg, 2014</xref>; <xref ref-type="bibr" rid="B36">Zhang and Vijg, 2018</xref>; <xref ref-type="bibr" rid="B16">Iourov et al., 2019</xref>). Genome instability at the chromosomal level (numerical and structural CINs) has been determined as a conserved mechanism for aging, as a whole, and, more particularly, for aging of the brain, a post-mitotic tissue with an extremely limited potential of cell renewal (<xref ref-type="bibr" rid="B33">Yurov et al., 2010</xref>; <xref ref-type="bibr" rid="B1">Andriani et al., 2017</xref>; <xref ref-type="bibr" rid="B29">Vijg et al., 2017</xref>). It appears that aging-related CIN leads to aging-related deterioration of the brain producing phenotypes similar to NDD (<xref ref-type="bibr" rid="B1">Andriani et al., 2017</xref>; <xref ref-type="bibr" rid="B36">Zhang and Vijg, 2018</xref>). Functionally, CIN is supposed to be an underlying cause of cellular (neuronal) senescence (<xref ref-type="bibr" rid="B33">Yurov et al., 2010</xref>; <xref ref-type="bibr" rid="B3">Arendt et al., 2017</xref>; <xref ref-type="bibr" rid="B36">Zhang and Vijg, 2018</xref>; <xref ref-type="bibr" rid="B16">Iourov et al., 2019</xref>). The latter has been recently demonstrated to represent a mechanism for both brain aging and NDD (<xref ref-type="bibr" rid="B5">Baker and Petersen, 2018</xref>). Therefore, one may conclude that the pathogenic pathways are likely to be shared by brain aging, neurodegeneration, and cancer.</p>
<p>NDD (e.g., Alzheimer’s disease) have been consistently shown to share biological hallmarks with cancer, which are, but not limited to, alterations to genome stability maintenance pathways (mitotic checkpoint, cell-cycle regulation, DNA replication/repair, programmed cell death, etc.) and CIN/genome instability (for review, see <xref ref-type="bibr" rid="B8">Driver, 2012</xref>, <xref ref-type="bibr" rid="B3">Arendt et al., 2017</xref>, <xref ref-type="bibr" rid="B23">Nudelman et al., 2019</xref>). More precisely, numerical CIN (aneuploidy) leading to chromosomal mosaicism is a mechanism for a variety of brain diseases including NDD. Somatic mosaicism and increased rates of aneuploidy and structural CIN have been identified in the neurodegenerating brain (Alzheimer’s disease and ataxia telangiectasia), schizophrenia brain, and individuals with intellectual disability and autism spectrum disorders. Mutations of specific genes implicated in genome stability maintenance pathways have been associated with NDD (<xref ref-type="bibr" rid="B12">Iourov et al., 2009a</xref>; <xref ref-type="bibr" rid="B13">Iourov et al., 2009b</xref>; <xref ref-type="bibr" rid="B2">Arendt et al., 2010</xref>; <xref ref-type="bibr" rid="B14">Iourov et al., 2011</xref>; <xref ref-type="bibr" rid="B17">Jeppesen et al., 2011</xref>; <xref ref-type="bibr" rid="B31">Yurov et al., 2014</xref>; <xref ref-type="bibr" rid="B4">Bajic et al., 2015</xref>; <xref ref-type="bibr" rid="B7">Caneus et al., 2018</xref>; <xref ref-type="bibr" rid="B25">Rohrback et al., 2018</xref>; <xref ref-type="bibr" rid="B32">Yurov et al., 2018</xref>; <xref ref-type="bibr" rid="B16">Iourov et al., 2019</xref>). Aneuploidy is a common feature of cancer cell populations and is likely to influence cancer behavior (for review, see <xref ref-type="bibr" rid="B27">Simonetti et al., 2019</xref>). Moreover, chromosomal mosaicism is a susceptibility factor for cancer (<xref ref-type="bibr" rid="B26">Schick et al., 2013</xref>; <xref ref-type="bibr" rid="B28">Vijg, 2014</xref>; <xref ref-type="bibr" rid="B22">Machiela, 2019</xref>). Genetic alterations to the genome stability maintenance pathways produced by copy number and sequence variations of the implicated genes are observed both in cancer and in the neurodegenerating brain (<xref ref-type="bibr" rid="B10">Granic et al., 2010</xref>; <xref ref-type="bibr" rid="B6">Bushman et al., 2015</xref>; <xref ref-type="bibr" rid="B11">Heng, 2015</xref>; <xref ref-type="bibr" rid="B7">Caneus et al., 2018</xref>; <xref ref-type="bibr" rid="B19">Lee et al., 2018</xref>). As noted before, a possible mechanism of neurodegeneration is DNA repair deficiency (<xref ref-type="bibr" rid="B17">Jeppesen et al., 2011</xref>). The later commonly leads to CIN and karyotypic chaos in a wide spectrum of cancers (<xref ref-type="bibr" rid="B8">Driver, 2012</xref>; <xref ref-type="bibr" rid="B11">Heng, 2015</xref>; <xref ref-type="bibr" rid="B24">Rangel et al., 2017</xref>). DNA replication stress seems to lie at the origins of CIN in the neurodegenerating brain of individuals with Alzheimer’s disease (<xref ref-type="bibr" rid="B34">Yurov et al., 2011</xref>). Likewise, this phenomenon negatively impacts chromosome segregation producing CIN during tumorigenesis (<xref ref-type="bibr" rid="B35">Zhang et al., 2019</xref>). Finally, cellular senescence is able to contribute both to neurodegeneration (brain aging deterioration) and to cancer (<xref ref-type="bibr" rid="B33">Yurov et al., 2010</xref>; <xref ref-type="bibr" rid="B28">Vijg, 2014</xref>; <xref ref-type="bibr" rid="B5">Baker and Petersen, 2018</xref>; <xref ref-type="bibr" rid="B22">Machiela, 2019</xref>). It appears that either neurodegeneration or cancer is more likely to result from complex genetic-environmental interactions, in which CIN plays a key role in the pathogenic cascade (<xref ref-type="bibr" rid="B15">Iourov et al., 2013</xref>; <xref ref-type="bibr" rid="B11">Heng, 2015</xref>). However, taking into account diverse consequences of “neurodegenerative” and “cancerous” CINs, there should be a number of differences between these types of chromosome/genome instability. For instance, the lack of convincing evidence for comorbidities such as NDD and brain cancers suggests that brain cells affected by CIN may have at least two alternative fates: (i) to become malignant (i.e., cancerization) and (ii) to be cleared by cell death (i.e., neurodegeneration). Therefore, there should be a striking difference in molecular pathways to cancer and NDD.</p>
<p>Since somatic mosaicism and CIN in the brain are more likely to have developmental origins (<xref ref-type="bibr" rid="B30">Yurov et al., 2007</xref>; <xref ref-type="bibr" rid="B25">Rohrback et al., 2018</xref>; <xref ref-type="bibr" rid="B32">Yurov et al., 2018</xref>; <xref ref-type="bibr" rid="B16">Iourov et al., 2019</xref>), alterations to programmed cell death may be an explanation of the presence of cells with abnormal chromosome complements (genomes) in the diseased brain (<xref ref-type="bibr" rid="B2">Arendt et al., 2010</xref>; <xref ref-type="bibr" rid="B33">Yurov et al., 2010</xref>; <xref ref-type="bibr" rid="B9">Fricker et al., 2018</xref>; <xref ref-type="bibr" rid="B16">Iourov et al., 2019</xref>). More precisely, abnormal neural cells generated during the development are not cleared throughout gestation and antenatal period. As a result, CIN-affected (abnormal) cellular populations alter brain functioning after birth (for more details, see <xref ref-type="bibr" rid="B30">Yurov et al., 2007</xref>; <xref ref-type="bibr" rid="B33">Yurov et al., 2010</xref>; <xref ref-type="bibr" rid="B25">Rohrback et al., 2018</xref>; <xref ref-type="bibr" rid="B16">Iourov et al., 2019</xref>). Thus, programmed cell death acts differently in the neurodegenerating brain and in cancer. The former demonstrates excessive neuronal cell loss probably mediated by CIN, whereas the latter is characterized by astonishing tolerance of cell populations to programed cell death (<xref ref-type="bibr" rid="B11">Heng, 2015</xref>; <xref ref-type="bibr" rid="B9">Fricker et al., 2018</xref>; <xref ref-type="bibr" rid="B16">Iourov et al., 2019</xref>). Therefore, cancer cells are likely to be affected by abnormal cell-death checkpoint in contrast to neuronal cells affected by “neurodegenerative CIN,” in which the checkpoint probably acts to an abnormal environmental trigger. Interestingly, CIN/aneuploidy is usually chromosome-specific in the diseased brain. In the Alzheimer’s disease brain, CIN commonly involves chromosome 21, whereas the selectively degenerating cerebellum of ataxia-telangiectasia individuals exhibits CIN commonly involving chromosome 14 (<xref ref-type="bibr" rid="B12">Iourov et al., 2009a</xref>; <xref ref-type="bibr" rid="B13">Iourov et al., 2009b</xref>; <xref ref-type="bibr" rid="B2">Arendt et al., 2010</xref>; <xref ref-type="bibr" rid="B10">Granic et al., 2010</xref>). This is generally not the case for the overwhelming majority of cancer cells expressing genetic defect specific for a cancer/ tumor type, karyotypic chaos, or numerical and structural CINs (<xref ref-type="bibr" rid="B11">Heng, 2015</xref>). The natural selection pressure against cells affected by non-specific CIN types and observations on patterns of CIN in the neurodegenerating brain suggest that neuronal cell populations affected by neurodegeneration possess primary genetic defects without progressive clonal evolution (<xref ref-type="bibr" rid="B12">Iourov et al., 2009a</xref>; <xref ref-type="bibr" rid="B2">Arendt et al., 2010</xref>; <xref ref-type="bibr" rid="B34">Yurov et al., 2011</xref>; <xref ref-type="bibr" rid="B15">Iourov et al., 2013</xref>; <xref ref-type="bibr" rid="B3">Arendt et al., 2017</xref>; <xref ref-type="bibr" rid="B20">Leija-Salazar et al., 2018</xref>). The latter, however, is shown to be an underlying cause of cancer (<xref ref-type="bibr" rid="B8">Driver, 2012</xref>; <xref ref-type="bibr" rid="B11">Heng, 2015</xref>; <xref ref-type="bibr" rid="B24">Rangel et al., 2017</xref>; <xref ref-type="bibr" rid="B27">Simonetti et al., 2019</xref>). Taking into consideration the aforementioned differences between cancer and NDD, we have proposed a theoretical model for CIN to mediate either cancer or neurodegeneration. Thus, “cancerous CIN” is likely to result from genetic-environment interactions and genetic defects, which render cells with unstable genomes tolerant to clearance (i.e., programmed cell death) and advantageous for proliferation over other cells. The malignancy is then achieved by clonal evolution. Alternatively, CIN and aneuploidy may possess a detrimental effect on cell growth under the normal growth conditions. In this case, cancerization is achieved through an adaptation of a subclone of cells to aneuploidy and CIN, which further evolves to a cell population with a fitness advantage (<xref ref-type="bibr" rid="B28">Vijg, 2014</xref>; <xref ref-type="bibr" rid="B11">Heng, 2015</xref>; <xref ref-type="bibr" rid="B35">Zhang et al., 2019</xref>). As a result, cells tolerating CIN without the loss form a stable cell population causing cancer invasion and metastasis (<xref ref-type="bibr" rid="B21">Loeb, 2010</xref>).</p>
<p>In contrast to cancer, neurodegeneration is likely to start because of the interaction between environmental trigger and CIN/genetic defects persisting in an appreciable proportion of brain cells. The interactions may launch a kind of “neuroprotective program” for clearance of CIN-affected cells. It appears that such “neuroprotective program” exists in the developing mammalian brain, which loses the majority of cells affected by CIN throughout gestation. It has been hypothesized that CIN/aneuploidy serves as an initiator of cell death (i.e., mitotic catastrophe) under natural selection in the developing brain (<xref ref-type="bibr" rid="B30">Yurov et al., 2007</xref>; <xref ref-type="bibr" rid="B33">Yurov et al., 2010</xref>; <xref ref-type="bibr" rid="B25">Rohrback et al., 2018</xref>; <xref ref-type="bibr" rid="B16">Iourov et al., 2019</xref>). Since CIN affects the critical number of neuronal cells (<xref ref-type="bibr" rid="B12">Iourov et al., 2009a</xref>), progressive loss of these cells would produce brain dysfunction leading to NDD phenotypes. <xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref> schematically shows our model for CIN contribution to cancer and neurodegeneration according to observations on CIN in the neurodegenerating brain in cancers (<xref ref-type="bibr" rid="B12">Iourov et al., 2009a</xref>; <xref ref-type="bibr" rid="B13">Iourov et al., 2009b</xref>; <xref ref-type="bibr" rid="B2">Arendt et al., 2010</xref>; <xref ref-type="bibr" rid="B10">Granic et al., 2010</xref>; <xref ref-type="bibr" rid="B14">Iourov et al., 2011</xref>; <xref ref-type="bibr" rid="B17">Jeppesen et al., 2011</xref>; <xref ref-type="bibr" rid="B34">Yurov et al., 2011</xref>; <xref ref-type="bibr" rid="B8">Driver, 2012</xref>; <xref ref-type="bibr" rid="B18">Kennedy et al., 2012</xref>; <xref ref-type="bibr" rid="B28">Vijg, 2014</xref>; <xref ref-type="bibr" rid="B31">Yurov et al., 2014</xref>; <xref ref-type="bibr" rid="B4">Bajic et al., 2015</xref>; <xref ref-type="bibr" rid="B11">Heng, 2015</xref>; <xref ref-type="bibr" rid="B3">Arendt et al., 2017</xref>; <xref ref-type="bibr" rid="B24">Rangel et al., 2017</xref>; <xref ref-type="bibr" rid="B7">Caneus et al., 2018</xref>; <xref ref-type="bibr" rid="B20">Leija-Salazar et al., 2018</xref>; <xref ref-type="bibr" rid="B32">Yurov et al., 2018</xref>; <xref ref-type="bibr" rid="B22">Machiela, 2019</xref>; <xref ref-type="bibr" rid="B27">Simonetti et al., 2019</xref>).</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>Theoretical model for CIN mediating <bold>(A)</bold> cancer and <bold>(B)</bold> neurodegeneration. <bold>(A)</bold> Genetic defects and genetic-environmental interactions may cause chromosomal/genomic changes, which produce CIN; alternatively, cell populations may adapt to aneuploidy and CIN evolving to a cell population with a fitness advantage. Cells affected by CIN and tolerating deteriorating effects of CIN on cellular homeostasis are able to evolve clonally to produce malignancy. <bold>(B)</bold> CIN/somatic mosaicism affecting a significant proportion of cells interacting with environmental triggers may result into progressive neuronal cell loss (neurodegeneration) under natural selection pressure and through the programmed cell death (N, normal neurons; CIN, neuronal cell affected by CIN). The model is based on the observations of CIN in the neurodegenerating brain and cancers (<xref ref-type="bibr" rid="B12">Iourov et al., 2009a</xref>; <xref ref-type="bibr" rid="B13">Iourov et al., 2009b</xref>; <xref ref-type="bibr" rid="B2">Arendt et al., 2010</xref>; <xref ref-type="bibr" rid="B10">Granic et al., 2010</xref>; <xref ref-type="bibr" rid="B14">Iourov et al., 2011</xref>; <xref ref-type="bibr" rid="B17">Jeppesen et al., 2011</xref>; <xref ref-type="bibr" rid="B34">Yurov et al., 2011</xref>; <xref ref-type="bibr" rid="B8">Driver, 2012</xref>; <xref ref-type="bibr" rid="B18">Kennedy et al., 2012</xref>; <xref ref-type="bibr" rid="B28">Vijg, 2014</xref>; <xref ref-type="bibr" rid="B31">Yurov et al., 2014</xref>; <xref ref-type="bibr" rid="B4">Bajic et al., 2015</xref>; <xref ref-type="bibr" rid="B11">Heng, 2015</xref>; <xref ref-type="bibr" rid="B3">Arendt et al., 2017</xref>; <xref ref-type="bibr" rid="B24">Rangel et al., 2017</xref>; <xref ref-type="bibr" rid="B7">Caneus et al., 2018</xref>; <xref ref-type="bibr" rid="B20">Leija-Salazar et al., 2018</xref>; <xref ref-type="bibr" rid="B32">Yurov et al., 2018</xref>; <xref ref-type="bibr" rid="B22">Machiela, 2019</xref>; <xref ref-type="bibr" rid="B27">Simonetti et al., 2019</xref>).</p>
</caption>
<graphic xlink:href="fgene-10-00892-g001"></graphic>
</fig>
<p>Understating the role of CIN in the neurodegeneration pathway is important for successful therapeutic interventions in NDD. Certainly, there is a need for further studies dedicated to analysis of the applicability of the “neurodegenerative CIN” model to describe molecular and cellular mechanisms for neurodegeneration. If the model is applicable, new opportunities for NDD prevention and treatments through the external control of CIN will be available.</p>
<sec id="s1">
<title>Author Contributions</title>
<p>All authors conceived the idea and made theoretical contributions to the manuscript. II wrote the manuscript.</p>
</sec>
<sec id="s2" sec-type="funding-information">
<title>Funding</title>
<p>Authors are partially supported by RFBR and CITMA according to the research project No. 18-515-34005. Prof. SG Vorsanova is supported by the Government Assignment of the Russian Ministry of Health, Assignment no. AAAA-A18-118051590122-7. Prof. IY Iourov is supported by the Government Assignment of the Russian Ministry of Science and Higher Education, Assignment no. AAAA-A19-119040490101-6.</p>
</sec>
<sec id="s3">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>Our communication is dedicated to Dr. Ilia Soloviev. We express our sincere gratitude to Dr. Maria A. Zelenova for <xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andriani</surname><given-names>G. A.</given-names></name><name><surname>Vijg</surname><given-names>J.</given-names></name><name><surname>Montagna</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Mechanisms and consequences of aneuploidy and chromosome instability in the aging brain</article-title>. <source/>Mech. Ageing Dev.
<volume>161</volume>, <fpage>19</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.mad.2016.03.007</pub-id>
<pub-id pub-id-type="pmid">27013377</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arendt</surname><given-names>T.</given-names></name><name><surname>Brückner</surname><given-names>M. K.</given-names></name><name><surname>Mosch</surname><given-names>B.</given-names></name><name><surname>Lösche</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Selective cell death of hyperploid neurons in Alzheimer’s disease</article-title>. <source/>Am. J. Pathol.
<volume>177</volume>, <fpage>15</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2010.090955</pub-id>
<pub-id pub-id-type="pmid">20472889</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arendt</surname><given-names>T.</given-names></name><name><surname>Stieler</surname><given-names>J.</given-names></name><name><surname>Ueberham</surname><given-names>U.</given-names></name></person-group> (<year>2017</year>). <article-title>Is sporadic Alzheimer’s disease a developmental disorder</article-title>? <source/>J. Neurochem.
<volume>143</volume>, <fpage>396</fpage>–<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.14036</pub-id>
<pub-id pub-id-type="pmid">28397252</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bajic</surname><given-names>V.</given-names></name><name><surname>Spremo-Potparevic</surname><given-names>B.</given-names></name><name><surname>Zivkovic</surname><given-names>L.</given-names></name><name><surname>Isenovic</surname><given-names>E. R.</given-names></name><name><surname>Arendt</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Cohesion and the aneuploid phenotype in Alzheimer’s disease: a tale of genome instability</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>55</volume>, <fpage>365</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.05.010</pub-id>
<pub-id pub-id-type="pmid">26003528</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baker</surname><given-names>D. J.</given-names></name><name><surname>Petersen</surname><given-names>R. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives</article-title>. <source/>J. Clin. Invest.
<volume>128</volume>, <fpage>1208</fpage>–<lpage>1216</lpage>. <pub-id pub-id-type="doi">10.1172/JCI95145</pub-id>
<pub-id pub-id-type="pmid">29457783</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bushman</surname><given-names>D. M.</given-names></name><name><surname>Kaeser</surname><given-names>G. E.</given-names></name><name><surname>Siddoway</surname><given-names>B.</given-names></name><name><surname>Westra</surname><given-names>J. W.</given-names></name><name><surname>Rivera</surname><given-names>R. R.</given-names></name><name><surname>Rehen</surname><given-names>S. K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Genomic mosaicism with increased amyloid precursor protein (<italic>APP</italic>) gene copy number in single neurons from sporadic Alzheimer’s disease brains</article-title>. <source/>Elife
<volume>4</volume>, <elocation-id>e05116</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.05116</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caneus</surname><given-names>J.</given-names></name><name><surname>Granic</surname><given-names>A.</given-names></name><name><surname>Rademakers</surname><given-names>R.</given-names></name><name><surname>Dickson</surname><given-names>D. W.</given-names></name><name><surname>Coughlan</surname><given-names>C. M.</given-names></name><name><surname>Chial</surname><given-names>H. J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by <italic>MAPT</italic> mutations</article-title>. <source/>Mol. Biol. Cell
<volume>29</volume>, <fpage>575</fpage>–<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E17-01-0031</pub-id>
<pub-id pub-id-type="pmid">29282277</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Driver</surname><given-names>J. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Understanding the link between cancer and neurodegeneration</article-title>. <source/>J. Geriatr. Oncol.
<volume>3</volume>, <fpage>58</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.jgo.2011.11.007</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fricker</surname><given-names>M.</given-names></name><name><surname>Tolkovsky</surname><given-names>A. M.</given-names></name><name><surname>Borutaite</surname><given-names>V.</given-names></name><name><surname>Coleman</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>G. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Neuronal cell death</article-title>. <source/>Physiol. Rev.
<volume>98</volume>, <fpage>813</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00011.2017</pub-id>
<pub-id pub-id-type="pmid">29488822</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Granic</surname><given-names>A.</given-names></name><name><surname>Padmanabhan</surname><given-names>J.</given-names></name><name><surname>Norden</surname><given-names>M.</given-names></name><name><surname>Potter</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP</article-title>. <source/>Mol. Biol. Cell
<volume>21</volume>, <fpage>511</fpage>–<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e09-10-0850</pub-id>
<pub-id pub-id-type="pmid">20032300</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Heng</surname><given-names>H. H.</given-names></name></person-group> (<year>2015</year>). <source/>Debating cancer: the paradox in cancer research. <publisher-loc>New Jersey</publisher-loc>: <publisher-name>World Scientific Publishing Company</publisher-name>. <pub-id pub-id-type="doi">10.1142/8879</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Liehr</surname><given-names>T.</given-names></name><name><surname>Kolotii</surname><given-names>A. D.</given-names></name><name><surname>Yurov</surname><given-names>Y. B.</given-names></name></person-group> (<year>2009</year>a). <article-title>Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain</article-title>. <source/>Hum. Mol. Genet.
<volume>18</volume>, <page-range>2656–2569</page-range>. <pub-id pub-id-type="doi">10.1093/hmg/ddp207</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Liehr</surname><given-names>T.</given-names></name><name><surname>Yurov</surname><given-names>Y. B.</given-names></name></person-group> (<year>2009</year>b). <article-title>Aneuploidy in the normal, Alzheimer’s disease and ataxia-telangiectasia brain: differential expression and pathological meaning</article-title>. <source/>Neurobiol. Dis.
<volume>34</volume>, <fpage>212</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2009.01.003</pub-id>
<pub-id pub-id-type="pmid">19344645</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Yurov</surname><given-names>Y. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Genomic landscape of the Alzheimer’s disease brain: chromosome instability—aneuploidy, but not tetraploidy—mediates neurodegeneration</article-title>. <source/>Neurodegener. Dis.
<volume>8</volume>, <fpage>35</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1159/000315398</pub-id>
<pub-id pub-id-type="pmid">21135562</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Yurov</surname><given-names>Y. B.</given-names></name></person-group> (<year>2013</year>). <article-title>Somatic cell genomics of brain disorders: a new opportunity to clarify genetic-environmental interactions</article-title>. <source/>Cytogenet. Genome Res.
<volume>139</volume>, <fpage>181</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1159/000347053</pub-id>
<pub-id pub-id-type="pmid">23428498</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Kutsev</surname><given-names>S. I.</given-names></name></person-group> (<year>2019</year>). <article-title>Ontogenetic and pathogenetic views on somatic chromosomal mosaicism</article-title>. <source/>Genes (Basel)
<volume>10</volume>, <fpage>379</fpage>. <pub-id pub-id-type="doi">10.3390/genes10050379</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jeppesen</surname><given-names>D. K.</given-names></name><name><surname>Bohr</surname><given-names>V. A.</given-names></name><name><surname>Stevnsner</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>DNA repair deficiency in neurodegeneration</article-title>. <source/>Prog. Neurobiol.
<volume>94</volume>, <fpage>166</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2011.04.013</pub-id>
<pub-id pub-id-type="pmid">21550379</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>S. R.</given-names></name><name><surname>Loeb</surname><given-names>L. A.</given-names></name><name><surname>Herr</surname><given-names>A. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Somatic mutations in aging, cancer and neurodegeneration</article-title>. <source/>Mech. Ageing Dev.
<volume>133</volume>, <fpage>118</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/j.mad.2011.10.009</pub-id>
<pub-id pub-id-type="pmid">22079405</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>M. H.</given-names></name><name><surname>Siddoway</surname><given-names>B.</given-names></name><name><surname>Kaeser</surname><given-names>G. E.</given-names></name><name><surname>Segota</surname><given-names>I.</given-names></name><name><surname>Rivera</surname><given-names>R.</given-names></name><name><surname>Romanow</surname><given-names>W. J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Somatic APP gene recombination in Alzheimer’s disease and normal neurons</article-title>. <source/>Nature
<volume>563</volume>, <fpage>639</fpage>–<lpage>645</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0718-6</pub-id>
<pub-id pub-id-type="pmid">30464338</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leija-Salazar</surname><given-names>M.</given-names></name><name><surname>Piette</surname><given-names>C.</given-names></name><name><surname>Proukakis</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Somatic mutations in neurodegeneration</article-title>. <source/>Neuropathol. Appl. Neurobiol.
<volume>44</volume>, <fpage>267</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1111/nan.12465</pub-id>
<pub-id pub-id-type="pmid">29369391</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Loeb</surname><given-names>L. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Mutator phenotype in cancer: origin and consequences</article-title>. <source/>Semin. Cancer Biol.
<volume>20</volume>, <fpage>279</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2010.10.006</pub-id>
<pub-id pub-id-type="pmid">20937389</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Machiela</surname><given-names>M. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Mosaicism, aging and cancer</article-title>. <source/>Curr. Opin. Oncol.
<volume>31</volume>, <fpage>108</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1097/CCO.0000000000000500</pub-id>
<pub-id pub-id-type="pmid">30585859</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Nudelman</surname><given-names>K. N. H.</given-names></name><name><surname>McDonald</surname><given-names>B. C.</given-names></name><name><surname>Lahiri</surname><given-names>D. K.</given-names></name><name><surname>Saykin</surname><given-names>A. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Biological hallmarks of cancer in Alzheimer’s disease</article-title>. <source/>Mol. Neurobiol.
<pub-id pub-id-type="doi">10.1007/s12035-019-1591-5</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rangel</surname><given-names>N.</given-names></name><name><surname>Forero-Castro</surname><given-names>M.</given-names></name><name><surname>Rondón-Lagos</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>New insights in the cytogenetic practice: karyotypic chaos, non-clonal chromosomal alterations and chromosomal instability in human cancer and therapy response</article-title>. <source/>Genes (Basel)
<volume>8</volume>, <fpage>155</fpage>. <pub-id pub-id-type="doi">10.3390/genes8060155</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rohrback</surname><given-names>S.</given-names></name><name><surname>Siddoway</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>C. S.</given-names></name><name><surname>Chun</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Genomic mosaicism in the developing and adult brain</article-title>. <source/>Dev. Neurobiol.
<volume>78</volume>, <fpage>1026</fpage>–<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22626</pub-id>
<pub-id pub-id-type="pmid">30027562</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schick</surname><given-names>U. M.</given-names></name><name><surname>McDavid</surname><given-names>A.</given-names></name><name><surname>Crane</surname><given-names>P. K.</given-names></name><name><surname>Weston</surname><given-names>N.</given-names></name><name><surname>Ehrlich</surname><given-names>K.</given-names></name><name><surname>Newton</surname><given-names>K. M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Confirmation of the reported association of clonal chromosomal mosaicism with an increased risk of incident hematologic cancer</article-title>. <source/>PLoS One
<volume>8</volume>, <elocation-id>e59823</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0059823</pub-id>
<pub-id pub-id-type="pmid">23533652</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simonetti</surname><given-names>G.</given-names></name><name><surname>Bruno</surname><given-names>S.</given-names></name><name><surname>Padella</surname><given-names>A.</given-names></name><name><surname>Tenti</surname><given-names>E.</given-names></name><name><surname>Martinelli</surname><given-names>G.</given-names></name></person-group> (<year>2019</year>). <article-title>Aneuploidy: cancer strength or vulnerability</article-title>? <source/>Int. J. Cancer
<volume>144</volume>, <fpage>8</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.31718</pub-id>
<pub-id pub-id-type="pmid">29981145</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vijg</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Somatic mutations, genome mosaicism, cancer and aging</article-title>. <source/>Curr. Opin. Genet. Dev.
<volume>26</volume>, <fpage>141</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2014.04.002</pub-id>
<pub-id pub-id-type="pmid">25282114</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vijg</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Milholland</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Genome instability: a conserved mechanism of ageing</article-title>? <source/>Essays Biochem.
<volume>61</volume>, <fpage>305</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1042/EBC20160082</pub-id>
<pub-id pub-id-type="pmid">28550046</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Liehr</surname><given-names>T.</given-names></name><name><surname>Kolotii</surname><given-names>A. D.</given-names></name><name><surname>Kutsev</surname><given-names>S. I.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Aneuploidy and confined chromosomal mosaicism in the developing human brain</article-title>. <source/>PLoS One
<volume>2</volume>, <elocation-id>e558</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0000558</pub-id>
<pub-id pub-id-type="pmid">17593959</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Liehr</surname><given-names>T.</given-names></name><name><surname>Kolotii</surname><given-names>A. D.</given-names></name><name><surname>Iourov</surname><given-names>I. Y.</given-names></name></person-group> (<year>2014</year>). <article-title>X chromosome aneuploidy in the Alzheimer’s disease brain</article-title>. <source/>Mol. Cytogenet.
<volume>7</volume>, <fpage>20</fpage>. <pub-id pub-id-type="doi">10.1186/1755-8166-7-20</pub-id>
<pub-id pub-id-type="pmid">24602248</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Iourov</surname><given-names>I. Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Human molecular neurocytogenetics</article-title>. <source/>Curr. Genet. Med. Rep.
<volume>6</volume>, <fpage>155</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1007/s40142-018-0152-y</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Iourov</surname><given-names>I. Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Ontogenetic variation of the human genome</article-title>. <source/>Curr. Genomics
<volume>11</volume>, <fpage>420</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.2174/138920210793175958</pub-id>
<pub-id pub-id-type="pmid">21358986</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Iourov</surname><given-names>I. Y.</given-names></name></person-group> (<year>2011</year>). <article-title>The DNA replication stress hypothesis of Alzheimer’s disease</article-title>. <source/>Sci. World J.
<volume>11</volume>, <fpage>2602</fpage>–<lpage>2612</lpage>. <pub-id pub-id-type="doi">10.1100/2011/625690</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B. N.</given-names></name><name><surname>Bueno Venegas</surname><given-names>A.</given-names></name><name><surname>Hickson</surname><given-names>I. D.</given-names></name><name><surname>Chu</surname><given-names>W. K.</given-names></name></person-group> (<year>2019</year>). <article-title>DNA replication stress and its impact on chromosome segregation and tumorigenesis</article-title>. <source/>Semin. Cancer Biol.
<volume>55</volume>, <fpage>61</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2018.04.005</pub-id>
<pub-id pub-id-type="pmid">29692334</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Vijg</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Somatic mutagenesis in mammals and its implications for human disease and aging</article-title>. <source/>Annu. Rev. Genet.
<volume>52</volume>, <fpage>397</fpage>–<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genet-120417-031501</pub-id>
<pub-id pub-id-type="pmid">30212236</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>